A DISCRETE EVENT SIMULATION MODEL FOR RENAL CELL CARCINOMA FOR USE IN A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Dansk, V [1 ]
Treharne, C. [2 ]
Santi, R. [2 ]
Malcolm, B. [3 ]
Johal, S. [2 ]
机构：
[1] PAREXEL, Stockholm, Sweden
[2] Parexel Int, London, England
[3] Bristol Myers Squibb, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2086
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM100
引用
收藏
页码：A748 / A748
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness of Total Hip and Knee Replacements for the Australian Population with Osteoarthritis: Discrete-Event Simulation Model
    Higashi, Hideki
    Barendregt, Jan J.
    PLOS ONE, 2011, 6 (09):
  • [22] Discrete Event Simulation Model for Cost-Effectiveness Evaluation of Screening for Asymptomatic Patients with Lower Extremity Arterial Disease
    Kamensky, Vojtech
    Rogalewicz, Vladimir
    Gajdos, Ondrej
    Donin, Gleb
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (18)
  • [23] A DISCRETE EVENT SIMULATION MODEL IN MAJOR DEPRESSIVE DISORDER-COST-EFFECTIVENESS ANALYSIS OF AGOMELATINE
    Felix, J.
    Almeida, J.
    Varandas, P.
    VALUE IN HEALTH, 2009, 12 (07) : A223 - A223
  • [24] Reorganizing the system of care surrounding laparoscopic surgery: A cost-effectiveness analysis using discrete-event simulation
    Stahl, JE
    Rattner, D
    Wiklund, R
    Lester, J
    Beinfeld, M
    Gazelle, GS
    MEDICAL DECISION MAKING, 2004, 24 (05) : 461 - 471
  • [25] COST-EFFECTIVENESS OF TREATMENT IN RENAL CELL CARCINOMA ADJUSTED TO THE CLASSIFICATION MODELS
    Sastre-Heres, Alejandro J.
    Iglesias Peinado, Irene
    Ruiz-Sanchez, Daniel
    Garcia Diaz, Benito
    Pena-Diaz, Jaime
    ACTA MEDICA MEDITERRANEA, 2016, 32 (05): : 1689 - 1695
  • [26] Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma in Sweden
    Johal, S.
    Johannesen, K. M.
    Malcolm, B.
    Doan, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] COST-EFFECTIVENESS OF SORAFENIB FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW
    Taheri, S.
    Motevalli, M. H.
    Peiravian, F.
    Yousefi, N.
    VALUE IN HEALTH, 2018, 21 : S42 - S42
  • [28] COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY
    Tatar, M.
    Akbulut, H.
    VALUE IN HEALTH, 2009, 12 (07) : A222 - A222
  • [29] Cost-Effectiveness of Immunotherapy Treatments for Renal Cell Carcinoma: A Systematic Review
    Philip, Errol J.
    Zhang, Sylvia
    Tahir, Peggy
    Kim, Daniel
    Wright, Francis
    Bell, Alexander
    Borno, Hala T.
    KIDNEY CANCER, 2021, 5 (01) : 47 - 62
  • [30] A REVIEW OF GLOBAL COST-EFFECTIVENESS STUDIES IN RENAL CELL CARCINOMA FOR AXITINIB
    Wang, B. C.
    Ren, H.
    Fumback, W.
    Guzauskas, G. F.
    VALUE IN HEALTH, 2017, 20 (05) : A111 - A111
12345